Benzylpenicillin Salts — Sodium/Potassium, Procaine, and Benzathine (Bicillin, Pen-G)
Dosage form:
Bicillin-1: powder for injectable solution containing 600,000 or 1,200,000 IU benzathine benzylpenicillin per vial.
Bicillin-3: benzathine benzylpenicillin + penicillin G sodium + procaine penicillin, 200,000 or 400,000 IU each per vial.
Bicillin-5: benzathine benzylpenicillin 1,200,000 IU + procaine penicillin 300,000 IU per vial.
Bicillin-3: benzathine benzylpenicillin + penicillin G sodium + procaine penicillin, 200,000 or 400,000 IU each per vial.
Bicillin-5: benzathine benzylpenicillin 1,200,000 IU + procaine penicillin 300,000 IU per vial.
Pharmacological group:
Penicillin-class antibiotics
Therapeutic use:
Diseases caused by susceptible microflora, mainly Gram-positive organisms and anaerobes
Dosage:
Dogs:
Penicillin G sodium or potassium: 20,000–40,000 IU/kg intravenously or intramuscularly every 4–8 hours.
Procaine penicillin G: 20,000–40,000 IU/kg intramuscularly or subcutaneously every 12–24 hours.
Benzathine penicillin G: 40,000 IU/kg intramuscularly every 5 days.
Procaine penicillin G: 20,000–40,000 IU/kg intramuscularly or subcutaneously every 12–24 hours.
Benzathine penicillin G: 40,000 IU/kg intramuscularly every 5 days.
Cats:
Penicillin G sodium or potassium: 20,000–40,000 IU/kg intravenously or intramuscularly every 4–8 hours.
Procaine penicillin G: 20,000–40,000 IU/kg intramuscularly or subcutaneously every 12–24 hours.
Benzathine penicillin G: 40,000 IU/kg intramuscularly every 5 days.
Procaine penicillin G: 20,000–40,000 IU/kg intramuscularly or subcutaneously every 12–24 hours.
Benzathine penicillin G: 40,000 IU/kg intramuscularly every 5 days.
Brinzolamide (Azopt)
Dosage form:
Ophthalmic drops
Pharmacological group:
Carbonic anhydrase inhibitor
Therapeutic use:
Reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Dosage:
Dogs:
1 drop in affected eye(s) 2–3 times daily
Cats:
1 drop in affected eye(s) 2–3 times daily
Bromhexine
Dosage form:
Tablets 4 mg and 8 mg; oral drops 8 mg/mL
Pharmacological group:
Mucolytic / Expectorant
Therapeutic use:
Respiratory diseases with viscous mucus secretion
Dosage:
Dogs:
2 mg/kg orally every 12 hours
Cats:
1 mg/kg orally once every 24 hours
Budesonide (Pulmicort, Rhinocort)
Dosage form:
Nebulizer suspension 0.25 mg/mL, 0.5 mg/mL
Pharmacological group:
Inhaled glucocorticoid (for obstructive airway diseases)
Therapeutic use:
Inhaled forms used in humans for asthma or allergic rhinitis. Inhaled budesonide has been reported to improve clinical signs and lung function parameters in cats with bronchial disease.
Dosage:
Dogs:
Empirically: 1–2 mL per nebulization session
Cats:
Empirically: 1–2 mL per nebulization session
Butorphanol (Torbugesic, Stadol)
Dosage form:
Injectable solution 10 mg/mL
Pharmacological group:
Opioid analgesic
Therapeutic use:
Analgesia and anesthesia; antitussive
Dosage:
Dogs:
Analgesia: 0.2–0.5 mg/kg intravenously, intramuscularly, or subcutaneously.
Antitussive: 0.05–0.1 mg/kg intravenously, intramuscularly, or subcutaneously; 0.5–1 mg/kg subcutaneously every 6–12 hours.
Antitussive: 0.05–0.1 mg/kg intravenously, intramuscularly, or subcutaneously; 0.5–1 mg/kg subcutaneously every 6–12 hours.
Cats:
Analgesia: 0.2–0.5 mg/kg intravenously, intramuscularly, or subcutaneously